Screener
Citius Oncology, Inc. CTOR EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Citius Oncology, Inc.’s 10-Q, filed August 14, 2026.
- Filed
- Aug 14, 2026, 4:35 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001213900-26-090184
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Nine Months Ended / June 30, 2026 | Nine Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Interest expense | (231,732) | (160,755) | (310,604) | (160,755) |
| Total Other Income (Expense), Net | (314,376) | (160,755) | 1,440,761 | (160,755) |
| Loss before Income Taxes | (9,031,193) | (5,105,716) | (41,141,927) | (18,971,993) |
| Income tax expense (benefit) | (107,347) | 264,240 | (74,317) | 792,720 |
| Net Loss | $(8,923,846) | $(5,369,956) | $(41,067,610) | $(19,764,713) |
| Net Loss Per Share - Basic and Diluted | $(0.08) | $(0.08) | $(0.42) | $(0.28) |
| Weighted Average Common Shares Outstanding | ||||
| Basic and diluted (includes pre-funded warrants from the December 2025 offering) | 107,890,452 | 71,552,402 | 98,413,989 | 71,552,402 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Citius Oncology, Inc.'s EPS (diluted)?
- Citius Oncology, Inc. (CTOR) reported EPS (diluted) of -$0.08 in Q2 2026.
- How has Citius Oncology, Inc.'s EPS (diluted) changed year-over-year?
- Citius Oncology, Inc.'s EPS (diluted) decreased by 0.0% year-over-year, from -$0.08 to -$0.08.
- What is the long-term trend for Citius Oncology, Inc.'s EPS (diluted)?
- Over 2 years (2023 to 2025), Citius Oncology, Inc.'s EPS (diluted) has grown at a 33.8% compound annual growth rate (CAGR), from -$0.19 to -$0.34.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Citius Oncology, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude